Literature DB >> 9880793

Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom.

K Oshikawa1, S Terada.   

Abstract

Two platelet aggregation inhibitors, ussuristatin 1 (US-1) and 2 (US-2), were newly isolated from the venom of Chinese viper (Agkistrodon ussuriensis) by SP-Toyopearl 650M column chromatography and reverse-phase HPLC. The Mrs of these polypeptides were estimated to be about 8,000 by SDS-PAGE. Analytical gel filtration revealed that US-2 exists as a dimer. Both polypeptides comprised 71 amino acids, whose sequences showed high similarities to those of other disintegrins. US-1 had a typical Arg-Gly-Asp (RGD) sequence, which is responsible for blocking the binding of fibrinogen to the receptor. In US-2, the corresponding sequence was Lys-Gly-Asp (KGD). US-1 strongly suppressed platelet aggregation induced by ADP, collagen, thrombin, and epinephrine with IC50 = 17-33 nM. US-2 also inhibited the platelet aggregation, but the IC50s were about ten times higher. US-1 also dose-dependently inhibited the adhesion of human melanoma cells to fibrinogen and fibronectin, while US-2 did not inhibit the cell adhesion to fibronectin. This indicates that the KGD-bearing disintegrin is a specific inhibitor for the fibrinogen receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880793     DOI: 10.1093/oxfordjournals.jbchem.a022264

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

1.  Structural analysis of the KGD sequence loop of barbourin, an alphaIIbbeta3-specific disintegrin.

Authors:  H Minoux; C Chipot; D Brown; B Maigret
Journal:  J Comput Aided Mol Des       Date:  2000-05       Impact factor: 3.686

2.  Arg-Tyr-Asp (RYD) and Arg-Cys-Asp (RCD) motifs in dendroaspin promote selective inhibition of beta1 and beta3 integrins.

Authors:  B Wattam; D Shang; S Rahman; S Egglezou; M Scully; V Kakkar; X Lu
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

Review 3.  Privileged frameworks from snake venom.

Authors:  T A Reeks; B G Fry; P F Alewood
Journal:  Cell Mol Life Sci       Date:  2015-02-19       Impact factor: 9.261

4.  Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.

Authors:  Juan J Calvete; M Paz Moreno-Murciano; R David G Theakston; Dariusz G Kisiel; Cezary Marcinkiewicz
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

5.  Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa.

Authors:  M Paz Moreno-Murciano; Daniel Monleón; Juan J Calvete; Bernardo Celda; Cezary Marcinkiewicz
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

6.  The platelet integrin alphaIIbbeta3 binds to the RGD and AGD motifs in fibrinogen.

Authors:  Juan Sánchez-Cortés; Milan Mrksich
Journal:  Chem Biol       Date:  2009-09-25

7.  Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox.

Authors:  Jacob A Galán; Elda E Sánchez; Alexis Rodríguez-Acosta; Julio G Soto; Sajid Bashir; Mary Ann McLane; Carrie Paquette-Straub; John C Pérez
Journal:  Toxicon       Date:  2008-02-19       Impact factor: 3.033

Review 8.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

Review 9.  ADAM-15 disintegrin-like domain structure and function.

Authors:  Dong Lu; Mike Scully; Vijay Kakkar; Xinjie Lu
Journal:  Toxins (Basel)       Date:  2010-10-19       Impact factor: 4.546

10.  The venom gland transcriptome of the Desert Massasauga rattlesnake (Sistrurus catenatus edwardsii): towards an understanding of venom composition among advanced snakes (Superfamily Colubroidea).

Authors:  Susanta Pahari; Stephen P Mackessy; R Manjunatha Kini
Journal:  BMC Mol Biol       Date:  2007-12-20       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.